vs

Side-by-side financial comparison of CLARIVATE PLC (CLVT) and Dolby Laboratories, Inc. (DLB). Click either name above to swap in a different company.

CLARIVATE PLC is the larger business by last-quarter revenue ($585.5M vs $395.6M, roughly 1.5× Dolby Laboratories, Inc.). Dolby Laboratories, Inc. runs the higher net margin — 24.0% vs -6.9%, a 30.9% gap on every dollar of revenue. On growth, Dolby Laboratories, Inc. posted the faster year-over-year revenue change (7.1% vs -1.4%). Over the past eight quarters, Dolby Laboratories, Inc.'s revenue compounded faster (13.9% CAGR vs -5.1%).

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.

CLVT vs DLB — Head-to-Head

Bigger by revenue
CLVT
CLVT
1.5× larger
CLVT
$585.5M
$395.6M
DLB
Growing faster (revenue YoY)
DLB
DLB
+8.4% gap
DLB
7.1%
-1.4%
CLVT
Higher net margin
DLB
DLB
30.9% more per $
DLB
24.0%
-6.9%
CLVT
Faster 2-yr revenue CAGR
DLB
DLB
Annualised
DLB
13.9%
-5.1%
CLVT

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CLVT
CLVT
DLB
DLB
Revenue
$585.5M
$395.6M
Net Profit
$-40.2M
$94.9M
Gross Margin
67.2%
88.7%
Operating Margin
5.2%
28.5%
Net Margin
-6.9%
24.0%
Revenue YoY
-1.4%
7.1%
Net Profit YoY
61.3%
3.4%
EPS (diluted)
$-0.06
$0.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLVT
CLVT
DLB
DLB
Q2 26
$395.6M
Q1 26
$585.5M
$346.7M
Q4 25
$617.0M
$346.7M
Q3 25
$623.1M
$307.0M
Q2 25
$621.4M
$315.5M
Q1 25
$593.7M
$369.6M
Q4 24
$663.0M
$357.0M
Q3 24
$622.2M
$304.8M
Net Profit
CLVT
CLVT
DLB
DLB
Q2 26
$94.9M
Q1 26
$-40.2M
$53.3M
Q4 25
$3.1M
$53.3M
Q3 25
$-28.3M
$49.3M
Q2 25
$-72.0M
$46.1M
Q1 25
$-103.9M
$91.8M
Q4 24
$-191.8M
$67.8M
Q3 24
$-65.6M
$58.6M
Gross Margin
CLVT
CLVT
DLB
DLB
Q2 26
88.7%
Q1 26
67.2%
87.5%
Q4 25
66.8%
87.5%
Q3 25
65.0%
87.1%
Q2 25
67.2%
86.1%
Q1 25
65.1%
90.3%
Q4 24
65.7%
88.6%
Q3 24
66.2%
88.8%
Operating Margin
CLVT
CLVT
DLB
DLB
Q2 26
28.5%
Q1 26
5.2%
17.9%
Q4 25
6.7%
17.9%
Q3 25
7.1%
9.7%
Q2 25
1.1%
15.1%
Q1 25
-3.5%
29.2%
Q4 24
-9.4%
22.4%
Q3 24
3.5%
15.2%
Net Margin
CLVT
CLVT
DLB
DLB
Q2 26
24.0%
Q1 26
-6.9%
15.4%
Q4 25
0.5%
15.4%
Q3 25
-4.5%
16.1%
Q2 25
-11.6%
14.6%
Q1 25
-17.5%
24.8%
Q4 24
-28.9%
19.0%
Q3 24
-10.5%
19.2%
EPS (diluted)
CLVT
CLVT
DLB
DLB
Q2 26
$0.99
Q1 26
$-0.06
$0.55
Q4 25
$0.00
$0.55
Q3 25
$-0.04
$0.50
Q2 25
$-0.11
$0.48
Q1 25
$-0.15
$0.94
Q4 24
$-0.27
$0.70
Q3 24
$-0.09
$0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLVT
CLVT
DLB
DLB
Cash + ST InvestmentsLiquidity on hand
$594.7M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$4.8B
$2.6B
Total Assets
$10.9B
$3.2B
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLVT
CLVT
DLB
DLB
Q2 26
$594.7M
Q1 26
$644.6M
Q4 25
$329.2M
$644.6M
Q3 25
$318.7M
$702.6M
Q2 25
$362.6M
$699.3M
Q1 25
$354.0M
$626.6M
Q4 24
$295.2M
$520.8M
Q3 24
$388.5M
$482.0M
Total Debt
CLVT
CLVT
DLB
DLB
Q2 26
Q1 26
$4.3B
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.6B
Stockholders' Equity
CLVT
CLVT
DLB
DLB
Q2 26
$2.6B
Q1 26
$4.8B
$2.6B
Q4 25
$4.8B
$2.6B
Q3 25
$4.9B
$2.6B
Q2 25
$5.0B
$2.6B
Q1 25
$5.0B
$2.6B
Q4 24
$5.1B
$2.5B
Q3 24
$5.5B
$2.5B
Total Assets
CLVT
CLVT
DLB
DLB
Q2 26
$3.2B
Q1 26
$10.9B
$3.2B
Q4 25
$11.1B
$3.2B
Q3 25
$11.2B
$3.2B
Q2 25
$11.4B
$3.2B
Q1 25
$11.5B
$3.2B
Q4 24
$11.5B
$3.2B
Q3 24
$12.0B
$3.1B
Debt / Equity
CLVT
CLVT
DLB
DLB
Q2 26
Q1 26
0.89×
Q4 25
0.89×
Q3 25
0.90×
Q2 25
0.90×
Q1 25
0.90×
Q4 24
0.88×
Q3 24
0.84×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLVT
CLVT
DLB
DLB
Operating Cash FlowLast quarter
$134.7M
$147.3M
Free Cash FlowOCF − Capex
$78.9M
FCF MarginFCF / Revenue
13.5%
Capex IntensityCapex / Revenue
9.5%
Cash ConversionOCF / Net Profit
1.55×
TTM Free Cash FlowTrailing 4 quarters
$333.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLVT
CLVT
DLB
DLB
Q2 26
$147.3M
Q1 26
$134.7M
$54.8M
Q4 25
$159.9M
$54.8M
Q3 25
$181.1M
$472.2M
Q2 25
$116.3M
$67.7M
Q1 25
$171.2M
$174.9M
Q4 24
$141.3M
$106.8M
Q3 24
$202.9M
$327.3M
Free Cash Flow
CLVT
CLVT
DLB
DLB
Q2 26
Q1 26
$78.9M
Q4 25
$89.2M
$50.2M
Q3 25
$115.5M
$435.9M
Q2 25
$50.3M
$61.3M
Q1 25
$110.3M
$168.0M
Q4 24
$59.1M
$100.0M
Q3 24
$126.3M
$297.2M
FCF Margin
CLVT
CLVT
DLB
DLB
Q2 26
Q1 26
13.5%
Q4 25
14.5%
14.5%
Q3 25
18.5%
142.0%
Q2 25
8.1%
19.4%
Q1 25
18.6%
45.5%
Q4 24
8.9%
28.0%
Q3 24
20.3%
97.5%
Capex Intensity
CLVT
CLVT
DLB
DLB
Q2 26
Q1 26
9.5%
Q4 25
11.5%
1.3%
Q3 25
10.5%
11.8%
Q2 25
10.6%
2.0%
Q1 25
10.3%
1.9%
Q4 24
12.4%
1.9%
Q3 24
12.3%
9.8%
Cash Conversion
CLVT
CLVT
DLB
DLB
Q2 26
1.55×
Q1 26
1.03×
Q4 25
51.58×
1.03×
Q3 25
9.57×
Q2 25
1.47×
Q1 25
1.91×
Q4 24
1.57×
Q3 24
5.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLVT
CLVT

Subscription$397.5M68%
Re-occurring$108.6M19%
Transactional$79.4M14%

DLB
DLB

Licensing$372.2M94%
Products and services$23.4M6%

Related Comparisons